W E Wade1, M A Chisholm. 1. Department of Clinical and Administrative Sciences, College of Pharmacy, University of Georgia, Athens 30602, USA.
Abstract
OBJECTIVE: Venous thrombosis and pulmonary embolisms are major complications associated with acute spinal cord injury. The purpose of this study was to perform a cost analysis on the two pharmacoprophylaxis regimens suggested for deep vein thrombosis prophylaxis in this population. METHODS: Efficacy and safety data were obtained from the literature. RESULTS: Results of the cost analysis demonstrates that adjusted dose unfractionated heparin produces a cost savings over enoxaparin at 30 mg every 12 hr. CONCLUSION: Further studies are needed to determine the most cost-effective therapy for preventing deep vein thrombi in this population.
OBJECTIVE:Venous thrombosis and pulmonary embolisms are major complications associated with acute spinal cord injury. The purpose of this study was to perform a cost analysis on the two pharmacoprophylaxis regimens suggested for deep vein thrombosis prophylaxis in this population. METHODS: Efficacy and safety data were obtained from the literature. RESULTS: Results of the cost analysis demonstrates that adjusted dose unfractionated heparin produces a cost savings over enoxaparin at 30 mg every 12 hr. CONCLUSION: Further studies are needed to determine the most cost-effective therapy for preventing deep vein thrombi in this population.
Authors: Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer Journal: Neurocrit Care Date: 2016-02 Impact factor: 3.210
Authors: Elena V Gospodarevskaya; Stacy K Goergen; Anthony H Harris; Thomas Chan; John F de Campo; Rory Wolfe; Eng T Gan; Michael B Wheeler; John McKay Journal: Cost Eff Resour Alloc Date: 2006-06-27